MedTrace Logo

Total Versus Partial Omentectomy in the Treatment of Gastric Cancer

NCT05238584 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-05-20

No results posted yet for this study

Summary

The main purpose of this study is to evaluate the role of the type of omentectomy (partial or total) in the treatment of Tis - T3 gastric cancer without serosal infiltration. The second purpose is to monitoring the blood levels of immunological factors (interleukins, T cell subtypes, etc.) pre-and postoperatively, depending on the type of omentectomy.

Conditions

  • Stomach Neoplasms
  • Interleukin
  • Stomach Cancer
  • Gastric Cancer
  • Digestive System Neoplasm

Interventions

PROCEDURE

Partial omentectomy

Partial omentectomy: with preservation of the greater omentum at \>2 cm from the gastroepiploic arcade.

Sponsors & Collaborators

  • National Institute of Oncology, Hungary

    collaborator OTHER

  • University of Pecs

    collaborator OTHER

  • Uzsoki Hospital

    collaborator OTHER

  • University of Debrecen

    lead OTHER

Principal Investigators

  • Dezső Tóth · University of Debrecen - Surgical Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2024-07-01

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05238584 on ClinicalTrials.gov